Profile of Oral Antidiabetic Sales at Pharmacy "X" Semarang City Period January – June 2024

Abstract

Indonesia ranks fifth in the world for diabetes mellitus (DM) sufferers and is expected to continue increasing until 2050 according to the International Diabetes Federation (IDF). The increase in DM cases will impact the fulfillment of the medication needs in the community. Based on this, the sales data of antidiabetic drugs need to be monitored to ensure that the drug stock is well available because the prevalence of diabetes continues to increase. This study aims to determine the quantity and types of oral antidiabetic medications sold at Pharmacy "X" in Semarang City with and without prescriptions during the period of January – June 2024. This research is a type of observational study with a descriptive method. Data collection was conducted retrospectively using purposive sampling technique. Sample data collection includes the number of drug sales with BPJS (Social Security Organizing Agency) prescriptions and non-BPJS prescriptions, as well as direct purchases without prescriptions, referred to as general sales. The research results show that the best-selling prescription drugs for both BPJS and non-BPJS (general) patients are metformin 500 mg, with sales of (64.51%) and (61%) respectively. Based on their pharmacological classification, the most sold group is biguanides at 64.87%, followed by sulfonylureas at 29.09%, and alpha-glucosidase inhibitors at 6.04%.